Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

The Safety and Effectiveness of ISIS 2922 in Patients With AIDS Who Have Cytomegalovirus (CMV) of the Eyes

ClinicalTrials.gov ID: NCT00002356

Public ClinicalTrials.gov record NCT00002356. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 5:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Study of the Safety and Efficacy of Intravitreal ISIS 2922 in Acquired Immune Deficiency Syndrome (AIDS) Patients With Cytomegalovirus Retinitis (NOTE: Restricted to Patients Who Rollover From Another Controlled ISIS 2922 Trial)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the efficacy and safety of ISIS 2922 in AIDS patients with Cytomegalovirus ( CMV ) retinitis who are unresponsive or intolerant to ganciclovir and/or foscarnet but are otherwise ineligible for ISIS Pharmaceuticals' controlled trials OR who have failed ISIS 2922 therapy on another controlled clinical trial. PER 2/8/96 AMENDMENT: Patients must rollover from another ISIS 2922 controlled trial.

Study identification

NCT ID
NCT00002356
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Ionis Pharmaceuticals, Inc.
Industry
Enrollment
Not listed

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 24, 2005

United States locations

U.S. sites
25
U.S. states
14
U.S. cities
22
Facility City State ZIP Site status
UCI College of Medicine Irvine California 92715 —
Retina - Vitreous Associates Med Group Los Angeles California 90017 —
Community Eye Med Group Pasadena California 911052536 —
San Diego Naval Hosp San Diego California 92134 —
Univ of California San Francisco / SF Gen Hosp San Francisco California 94110 —
Santa Clara Valley Med Ctr San Jose California 95128 —
Univ of Colorado Health Sciences Ctr Denver Colorado 80262 —
Dr Alan Palestine Washington D.C. District of Columbia 20036 —
Dr Julio Perez Fort Lauderdale Florida 33060 —
Bascon Palmer Eye Institute Miami Florida 33136 —
Emory Univ School of Medicine / Emory Eye Ctr Atlanta Georgia 30322 —
Georgia Retina Atlanta Georgia 30327 —
Univ of Illinois Chicago Illinois 60612 —
Indiana Univ Med Ctr Indianapolis Indiana 46202 —
Tulane Univ New Orleans Louisiana 70112 —
Vitreo - Retinal Consultants New York New York 10028 —
Charlotte Eye Ear Nose & Throat Association Charlotte North Carolina 28204 —
Duke Univ Durham North Carolina 27710 —
Hahnemann Univ Hosp Philadelphia Pennsylvania 19102 —
Graduate Hosp Philadelphia Pennsylvania 191461192 —
Univ of Texas Southwestern Med Ctr of Dallas Dallas Texas 752359057 —
Vitreoretinal Consultants Houston Texas 77004 —
Baylor College of Medicine Houston Texas 77030 —
Virginia Eye Consultants Norfolk Virginia 23507 —
Novum Inc Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002356, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 24, 2005 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00002356 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →